Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.
Harada H, Suefuji H, Mori K, Ishikawa H, Nakamura M, Tokumaru S, Murakami M, Ogino T, Iwata H, Tatebe H, Kubo N, Waki T, Yoshida D, Nakamura M, Hashimoto T, Araya M, Nakajima M, Nakayama H, Satouchi M, Shioyama Y. Harada H, et al. Among authors: iwata h. Radiother Oncol. 2024 Jun 18:110385. doi: 10.1016/j.radonc.2024.110385. Online ahead of print. Radiother Oncol. 2024. PMID: 38901770
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5.
Cortés J, Hurvitz SA, O'Shaughnessy J, Delaloge S, Iwata H, Rugo HS, Neven P, Kanagavel D, Cohen P, Paux G, Cartot-Cotton S, Stefanova-Urena M, Deyme L, Aouni J, Sebastien B, Bardia A. Cortés J, et al. Among authors: iwata h. J Clin Oncol. 2024 Jun 18:JCO2302036. doi: 10.1200/JCO.23.02036. Online ahead of print. J Clin Oncol. 2024. PMID: 38889373
Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
Miyauchi K, Iwata H, Nishizaki Y, Inoue T, Hirayama A, Kimura K, Ozaki Y, Murohara T, Ueshima K, Kuwabara Y, Tanaka-Mizuno S, Yanagisawa N, Sato T, Daida H; RESPECT-EPA Investigators. Miyauchi K, et al. Among authors: iwata h. Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520. Online ahead of print. Circulation. 2024. PMID: 38873793
Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageals cell carcinoma: a multi-center retrospective Japanese cohort study.
Ogawa K, Ishikawa H, Toyozumi T, Noma K, Kono K, Hojo H, Tamamura H, Azami Y, Ishida T, Nabeya Y, Iwata H, Araya M, Tokumaru S, Maruo K, Oda T, Matsubara H. Ogawa K, et al. Among authors: iwata h. Esophagus. 2024 Jun 6. doi: 10.1007/s10388-024-01068-6. Online ahead of print. Esophagus. 2024. PMID: 38844703
Maternal pre-pregnancy body mass index and related factors: A cross-sectional analysis from the Japan Environment and Children's Study.
Saijo Y, Yoshioka E, Sato Y, Kunori Y, Kanaya T, Nakanishi K, Kato Y, Nagaya K, Takahashi S, Ito Y, Iwata H, Yamaguchi T, Miyashita C, Itoh S, Kishi R; Japan Environment and Children’s Study (JECS) Group. Saijo Y, et al. Among authors: iwata h. PLoS One. 2024 Jun 4;19(6):e0304844. doi: 10.1371/journal.pone.0304844. eCollection 2024. PLoS One. 2024. PMID: 38833493 Free PMC article.
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial.
Cortés J, Hurvitz SA, Im SA, Iwata H, Curigliano G, Kim SB, Chiu JWY, Pedrini JL, Li W, Yonemori K, Bianchini G, Loi S, Borges GS, Wang X, Bachelot T, Nakatani S, Ashfaque S, Liang Z, Egorov A, Hamilton E. Cortés J, et al. Among authors: iwata h. Nat Med. 2024 Jun 2. doi: 10.1038/s41591-024-03021-7. Online ahead of print. Nat Med. 2024. PMID: 38825627
2,985 results